Redhill Biopharma
RDHL
£1.11
Share price
-9.20%
Change (1 day)
-85.53%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Net assets
Net assets on the balance sheet as of December 2024 : -£3.51 Million
According to Redhill Biopharma's latest financial reports the company has -£3.51 Million in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Redhill Biopharma - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $£1.62 M | -104.06% |
| 2022-12-31 | $-£40.01 Million | -708.48% |
| 2021-12-31 | $£6.57 M | -35.36% |
| 2020-12-31 | $£10.17 M | -77.77% |
| 2019-12-31 | $£45.75 M | 13.47% |
| 2018-12-31 | $£40.32 M | 20.93% |
| 2017-12-31 | $£33.34 M | -34.38% |
| 2016-12-31 | $£50.81 M | 25.35% |
| 2015-12-31 | $£40.53 M | 152.36% |
| 2014-12-31 | $£16.06 M | 122.21% |
| 2013-12-31 | $£7.22 M | -38.56% |
| 2012-12-31 | $£11.76 M | -2.65% |
| 2011-12-31 | $£12.08 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | £60.28 B | -1,719,339.80% | 🇫🇷 France |
 Merck MRK | £36.24 B | -1,033,625.52% | 🇺🇸 USA |
 GlaxoSmithKline GSK | £13.21 B | -376,828.59% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | £1.33 B | -38,090.39% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | £4.69 B | -133,967.18% | 🇮🇱 Israel |